Healthcare -
Biotechnology - NASDAQ - US
$ 6.27
0.642 %
$ 428 M
Market Cap
-3.15
P/E
EYPT - LONG-TERM DEBT
Long-term Debt EYPT - EyePoint Pharmaceuticals, Inc.
4.91 M
LAST VALUE
-64.27%
2 YEAR CAGR
-22.29%
5 YEAR CAGR
0.00%
10 YEAR CAGR